Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.

<h4>Background</h4>Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in...

Full description

Saved in:
Bibliographic Details
Main Authors: Subramanian Swaminathan, Vanamail Perumal, Srividya Adinarayanan, Krishnamoorthy Kaliannagounder, Ravi Rengachari, Jambulingam Purushothaman
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001926&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849720408271486976
author Subramanian Swaminathan
Vanamail Perumal
Srividya Adinarayanan
Krishnamoorthy Kaliannagounder
Ravi Rengachari
Jambulingam Purushothaman
author_facet Subramanian Swaminathan
Vanamail Perumal
Srividya Adinarayanan
Krishnamoorthy Kaliannagounder
Ravi Rengachari
Jambulingam Purushothaman
author_sort Subramanian Swaminathan
collection DOAJ
description <h4>Background</h4>Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs that have completed at least five rounds of mass drug administration (MDA) each with >65% coverage and with microfilaria (Mf) levels <1% in the monitored sites form the basis for stopping the MDA. Despite its rigour, this multi-step process is likely to miss sites with transmission potential ('hotspots') and its statistical assumptions for sampling and threshold levels for decision-making have not been validated. We addressed these issues in a large-scale epidemiological study in two primary health centres in Thanjavur district, India, endemic for bancroftian filariasis that had undergone eight rounds of MDA.<h4>Methodology/principal findings</h4>The prevalence and intensity of Mf (per 60 µl blood) were 0.2% and 0.004 respectively in the survey that covered >70% of 50,363 population. The corresponding values for Ag were 2.3% and 17.3 Ag-units respectively. Ag-prevalence ranged from 0.7 to 0.9%, in children (2-10 years) and 2.7 to 3.0% in adults. Although the Mf-levels in the survey and the sentinel/spot check sites were <1% and Ag-level was <2% in children, we identified 7 "residual" (Mf-prevalence ≥ 1%, irrespective of Ag-status in children) and 17 "transmission" (at least one Ag-positive child born during the MDA period) hotspots. Antigenaemic persons were clustered both at household and site levels. We identified an Ag-prevalence of ~1% in children (equivalent to 0.4% community Mf-prevalence) as a possible threshold value for stopping MDA.<h4>Conclusions/significance</h4>Existence of 'hotspots' and spatial clustering of infections in the study area indicate the need for developing good surveillance strategies for detecting 'hotspots', adopting evidence-based sampling strategies and evaluation unit size for TAS.
format Article
id doaj-art-8a8679d3f88d41e8a6742d5eb57adac7
institution DOAJ
issn 1935-2727
1935-2735
language English
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-8a8679d3f88d41e8a6742d5eb57adac72025-08-20T03:11:55ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352012-01-01611e192610.1371/journal.pntd.0001926Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.Subramanian SwaminathanVanamail PerumalSrividya AdinarayananKrishnamoorthy KaliannagounderRavi RengachariJambulingam Purushothaman<h4>Background</h4>Monitoring and evaluation guidelines of the programme to eliminate lymphatic filariasis require impact assessments in at least one sentinel and one spot-check site in each implementation unit (IU). Transmission assessment surveys (TAS) that assess antigenaemia (Ag) in children in IUs that have completed at least five rounds of mass drug administration (MDA) each with >65% coverage and with microfilaria (Mf) levels <1% in the monitored sites form the basis for stopping the MDA. Despite its rigour, this multi-step process is likely to miss sites with transmission potential ('hotspots') and its statistical assumptions for sampling and threshold levels for decision-making have not been validated. We addressed these issues in a large-scale epidemiological study in two primary health centres in Thanjavur district, India, endemic for bancroftian filariasis that had undergone eight rounds of MDA.<h4>Methodology/principal findings</h4>The prevalence and intensity of Mf (per 60 µl blood) were 0.2% and 0.004 respectively in the survey that covered >70% of 50,363 population. The corresponding values for Ag were 2.3% and 17.3 Ag-units respectively. Ag-prevalence ranged from 0.7 to 0.9%, in children (2-10 years) and 2.7 to 3.0% in adults. Although the Mf-levels in the survey and the sentinel/spot check sites were <1% and Ag-level was <2% in children, we identified 7 "residual" (Mf-prevalence ≥ 1%, irrespective of Ag-status in children) and 17 "transmission" (at least one Ag-positive child born during the MDA period) hotspots. Antigenaemic persons were clustered both at household and site levels. We identified an Ag-prevalence of ~1% in children (equivalent to 0.4% community Mf-prevalence) as a possible threshold value for stopping MDA.<h4>Conclusions/significance</h4>Existence of 'hotspots' and spatial clustering of infections in the study area indicate the need for developing good surveillance strategies for detecting 'hotspots', adopting evidence-based sampling strategies and evaluation unit size for TAS.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001926&type=printable
spellingShingle Subramanian Swaminathan
Vanamail Perumal
Srividya Adinarayanan
Krishnamoorthy Kaliannagounder
Ravi Rengachari
Jambulingam Purushothaman
Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
PLoS Neglected Tropical Diseases
title Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
title_full Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
title_fullStr Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
title_full_unstemmed Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
title_short Epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in India: implications for monitoring and evaluation.
title_sort epidemiological assessment of eight rounds of mass drug administration for lymphatic filariasis in india implications for monitoring and evaluation
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0001926&type=printable
work_keys_str_mv AT subramanianswaminathan epidemiologicalassessmentofeightroundsofmassdrugadministrationforlymphaticfilariasisinindiaimplicationsformonitoringandevaluation
AT vanamailperumal epidemiologicalassessmentofeightroundsofmassdrugadministrationforlymphaticfilariasisinindiaimplicationsformonitoringandevaluation
AT srividyaadinarayanan epidemiologicalassessmentofeightroundsofmassdrugadministrationforlymphaticfilariasisinindiaimplicationsformonitoringandevaluation
AT krishnamoorthykaliannagounder epidemiologicalassessmentofeightroundsofmassdrugadministrationforlymphaticfilariasisinindiaimplicationsformonitoringandevaluation
AT ravirengachari epidemiologicalassessmentofeightroundsofmassdrugadministrationforlymphaticfilariasisinindiaimplicationsformonitoringandevaluation
AT jambulingampurushothaman epidemiologicalassessmentofeightroundsofmassdrugadministrationforlymphaticfilariasisinindiaimplicationsformonitoringandevaluation